Mkts

Coya Therapeutics, Inc.

NASDAQ: COYA
$2.95-0.03 (-1.01%)
As of Nov 20, 4:00 PM ET

Key statistics

Day range
2.903.11
52-week range
2.726.62
Today
Open2.94
Previous close2.95
Volume—
Valuation
Market cap69.90M
P/E ratio—
EPS (TTM)-1.07
Income & risk
Dividend / yield—
Beta0.81
Avg volume154.5K
Discussion

COYA News

Stories mentioning COYA from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue251.003,9603,564164.00258.002.000.003,425
Cost of Goods Sold
Gross Profit
Operating Expenses
Research & Development
Sales General & Admin
Total Operating Expenses7,8919,9915,9976,5787,9354,0834,4506,661
Operating Income (Loss)(7,640)(6,030)(2,433)(6,415)(7,677)(4,081)(4,450)(3,236)
Interest Income
Interest Expense
Other Expense433.00325.00317.00320.00370.00445.00429.00344.00
Pretax Income(7,207)(6,095)(7,307)(2,892)
Tax Provision0.000.00
Net Income (Loss)(7,207)(5,708)(2,116)(6,095)(7,307)(2,916)(4,021)(2,892)
Earnings Per Share (Basic)(0.32)(0.34)(0.13)(0.36)(0.44)(0.19)(0.26)(0.19)
Earnings Per Share (Diluted)(0.32)(0.34)(0.13)(0.36)(0.44)(0.19)(0.26)(0.19)
Weighted Average Shares Outstanding (Basic)22,64416,73016,73316,72516,72115,23915,22114,915
Weighted Average Shares Outstanding (Diluted)22,64416,73016,73316,72516,72115,23915,22114,915

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About COYA

Coya Therapeutics, Inc. (NASDAQ: COYA) is a stock listed on the Nasdaq Stock Market under the ticker symbol COYA. It last traded at $2.95 (Nov 20, 2026, 4:00 PM ET), down 1.0% on the day. That gives Coya Therapeutics a market capitalisation of $69.9M.

Over the past 52 weeks COYA has traded between $2.72 and $6.62.

Revenue for the quarter ended Mar 31, 2026 was $251.0K; a net loss of $7.2M. Revenue was down 2.7% from $258.0K in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$251.0K-$7.2M-2871.3%
Dec 31, 2025$4.0M-$5.7M-144.1%
Sep 30, 2025$3.6M-$2.1M-59.4%
Jun 30, 2025$164.0K-$6.1M-3716.5%

From Coya Therapeutics’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…